Real-time AI-powered analysis for TMO with price targets, technical indicators (RSI, MACD, SMA), institutional money flow, and news-based signals.
Unlock Full Pro Analysis
Real-time alerts, price targets, institutional flow & more — one-time $19.95.
Free summary — full analysis below.
Thermo Fisher Scientific Inc.
Pre-Market & After Hours is Pro Only
Upgrade to unlock this and all premium features
Oct 8, 05:36 AM
Confidence Score is Pro Only
Upgrade to unlock this and all premium features
Optimal Buy & Sell Zones is Pro Only
Upgrade to unlock this and all premium features
Strong Uptrend — Price above SMA50 & SMA200, Golden Cross
Total Conviction Scorecard is Pro Only
Upgrade to unlock this and all premium features
Optimal Buy & Sell Zones is Pro Only
Upgrade to unlock this and all premium features
$-32.27 (-4.6%) from high
Day's Range: $651.12 – $671.66
+$226.79 (+52.1%) above low
▲ Above — short-term uptrend (bullish)
▲ Above — long-term uptrend (bullish)
✓ 0.8x avg — normal activity, signals are reliable
✓ Normal — healthy trading conditions
RSI, MACD & SMA based on daily closes — update at market close. Live price shown separately.
Institutional Money Flow is Pro Only
Upgrade to unlock this and all premium features
Phantom Flow is Pro Only
Upgrade to unlock this and all premium features
Smart Money Flow Index is Pro Only
Upgrade to unlock this and all premium features
Risk Score is Pro Only
Upgrade to unlock this and all premium features
Thermo Fisher's recent partnerships and strong Q3 guidance highlight robust long-term growth potential. Multiple financial institutions have raised their price targets, reflecting significant confidence in the company's market position.

Quantum BioPharma (QNTM) Enlists Thermo Fisher's Clinical Research Business to Launch Phase 2 Lucid-MS Trial
Evercore ISI Adjusts Thermo Fisher Scientific Price Target to $690 From $570

Is This the Right Time to Add TMO Stock to Your Portfolio?

Cell-Based Assay & High Content Screening Market Report Reveals Why Technology Is Outpacing the Market, Profiling Thermo Fisher, Roche, Sartorius, Revvity & 50 Other Key Players

JPMorgan reveals stocks worth buying in October 2026
Disclaimer: This analysis is AI-generated and should not be considered financial advice. Always consult a qualified financial advisor before making investment decisions.
Our AI engine analyzes TMO across technicals (RSI, MACD, SMA50/200), institutional money flow (OBV, SEC 13D/13G filings), news sentiment, and price action to produce a real-time buy/sell signal with a confidence score. The recommendation updates every time the analysis runs.
The analysis calculates optimal entry and exit price targets for TMO using support/resistance levels, moving-average structure, and momentum. These levels are dynamic and recompute as new market data arrives.
RSI measures whether TMO is overbought or oversold; MACD shows momentum and trend shifts. A bullish MACD crossover with RSI below 70 often signals continued upside, while divergence can warn of a reversal.
We track institutional positioning in TMO through On-Balance Volume (OBV) money flow and SEC Schedule 13D/13G filings — the same disclosures activist investors and large funds must file. Rising OBV plus new 13D filings typically indicate smart-money accumulation.
Key risks for TMO include valuation compression, sector rotation, earnings volatility, and macro factors such as rates and inflation. The analysis grades risk from very low to very high based on volatility, drawdown history, and beta.
The TMO analysis combines real-time market data, technical indicators, institutional flow, and news-based sentiment. It is a decision-support tool, not financial advice — always do your own research and consider your risk tolerance before investing.
Market Intelligence provides AI-powered stock & ETF analysis for informational purposes only and does not constitute financial advice.